Charles Schwab’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,518
| Closed | -$246K | – | 3501 |
|
|
2021
Q2 | $246K | Sell |
2,518
-910
| -27% | -$88.9K | ﹤0.01% | 3258 |
|
|
2021
Q1 | $350K | Sell |
3,428
-171
| -5% | -$17.5K | ﹤0.01% | 3199 |
|
|
2020
Q4 | $355K | Buy |
3,599
+62
| +2% | +$6.12K | ﹤0.01% | 3101 |
|
|
2020
Q3 | $1.7M | Buy |
3,537
+1,380
| +64% | +$664K | ﹤0.01% | 2545 |
|
|
2020
Q2 | $1.67M | Buy |
2,157
+210
| +11% | +$163K | ﹤0.01% | 2471 |
|
|
2020
Q1 | $1.35M | Buy |
1,947
+23
| +1% | +$16K | ﹤0.01% | 2413 |
|
|
2019
Q4 | $1.77M | Buy |
+1,924
| New | +$1.77M | ﹤0.01% | 2454 |
|